by Jordana Choucair | Dec 9, 2021 | Opioid/Substance Use Disorders
AbbVie Inc.’s Allergan unit will pay up to $200 million to New York state and two counties to settle claims that it allowed opioid painkillers to overwhelm the region. State Attorney General Letitia James said that the funding will go toward opioid treatment,...
by Jordana Choucair | Dec 9, 2021 | Opioid/Substance Use Disorders
The Substance Abuse and Mental Health Services Administration announced it will distribute $30 million in grants to providers to boost harm reduction strategies. State and local governments, community-based organizations, and primary and behavioral health...
by Jordana Choucair | Dec 9, 2021 | Payers
The CMS issued a notice announcing that health insurers won’t be required to implement new rules intended to speed up their data-sharing efforts until the agency establishes a standard way to share the data. The rules were set to take effect January 1, 2022. The...
by Jordana Choucair | Dec 8, 2021 | D.C. News
The House passed legislation to raise the country’s borrowing liming and delay scheduled Medicare cuts. The bill delays across-the-board reductions to provider Medicare reimbursements until March 31, 2022, after which 1 percent reductions would kick in. The Senate is...
by Jordana Choucair | Dec 8, 2021 | D.C. News
A U.S. district court in Georgia halted the Biden administration’s vaccine mandate for federal contractors, siding with the Associated Builders and Contractors that President Biden likely exceeded his authority. The court told the Biden administration to halt...
by Jordana Choucair | Dec 8, 2021 | Life Sciences
Pfizer Inc.-BioNTech SE announced that a third dose of their COVID-19 vaccine neutralized the omicron variant and raised antibodies 25-fold in initial lab studies. While the companies said the results offer reassurance that the current formulations will protect...
Recent Comments